TITLE

Advances in Culture and Manipulation of Human Pluripotent Stem Cells

AUTHOR(S)
Qian, X.; Villa-Diaz, L.G.; Krebsbach, P.H.
PUB. DATE
November 2013
SOURCE
Journal of Dental Research;Nov2013, Vol. 92 Issue 11, p956
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recent advances in the understanding of pluripotent stem cell biology and emerging technologies to reprogram somatic cells to a stem cell–like state are helping bring stem cell therapies for a range of human disorders closer to clinical reality. Human pluripotent stem cells (hPSCs) have become a promising resource for regenerative medicine and research into early development because these cells are able to self-renew indefinitely and are capable of differentiation into specialized cell types of all 3 germ layers and trophoectoderm. Human PSCs include embryonic stem cells (hESCs) derived from the inner cell mass of blastocyst-stage embryos and induced pluripotent stem cells (hiPSCs) generated via the reprogramming of somatic cells by the overexpression of key transcription factors. The application of hiPSCs and the finding that somatic cells can be directly reprogrammed into different cell types will likely have a significant impact on regenerative medicine. However, a major limitation for successful therapeutic application of hPSCs and their derivatives is the potential xenogeneic contamination and instability of current culture conditions. This review summarizes recent advances in hPSC culture and methods to induce controlled lineage differentiation through regulation of cell-signaling pathways and manipulation of gene expression as well as new trends in direct reprogramming of somatic cells.
ACCESSION #
91099213

 

Related Articles

  • Zfp296 Is a Novel, Pluripotent-Specific Reprogramming Factor. Fischedick, Gerrit; Klein, Diana C.; Wu, Guangming; Esch, Daniel; Höing, Susanne; Han, Dong Wook; Reinhardt, Peter; Hergarten, Kerstin; Tapia, Natalia; Schöler, Hans R.; Sterneckert, Jared L. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Expression of the four transcription factors Oct4, Sox2, Klf4, and c-Myc (OSKM) is sufficient to reprogram somatic cells into induced pluripotent stem (iPSCs). However, this process is slow and inefficient compared with the fusion of somatic cells with embryonic stem cells (ESCs), indicating...

  • Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Yingzi Oh; Heming Wei; Dongrui Ma; Xiaoming Sun; Liew, Reginald // Heart;Mar2012, Vol. 98 Issue 6, p443 

    The emergence of induced pluripotent stem cell (iPSC) technology has had a great impact on the field of medicine ever since the ground-breaking discovery in 2006 that overexpression of four specific transcription factors was able to turn back the developmental clock of somatic cells into an...

  • Experimental approaches for the generation of induced pluripotent stem cells. Sommer, Cesar A.; Mostoslavsky, Gustavo // Stem Cell Research & Therapy;2010, Vol. 1 Issue 3, p1 

    Derivation of autologous induced pluripotent stem cells (iPSCs) through direct reprogramming of easily accessible somatic cells holds the potential to transform the field of regenerative medicine. Since Takahashi and Yamanaka's groundbreaking study describing the generation of iPSCs by...

  • Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective. Liang, Gaoyang; Zhang, Yi // Cell Research;Jan2013, Vol. 23 Issue 1, p49 

    Pluripotent stem cells, like embryonic stem cells (ESCs), have specialized epigenetic landscapes, which are important for pluripotency maintenance. Transcription factor-mediated generation of induced pluripotent stem cells (iPSCs) requires global change of somatic cell epigenetic status into an...

  • The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Mansour, Abed AlFatah; Gafni, Ohad; Weinberger, Leehee; Zviran, Asaf; Ayyash, Muneef; Rais, Yoach; Krupalnik, Vladislav; Zerbib, Mirie; Amann-Zalcenstein, Daniela; Maza, Itay; Geula, Shay; Viukov, Sergey; Holtzman, Liad; Pribluda, Ariel; Canaani, Eli; Horn-Saban, Shirley; Amit, Ido; Novershtern, Noa; Hanna, Jacob H. // Nature;8/16/2012, Vol. 488 Issue 7411, p409 

    Induced pluripotent stem cells (iPSCs) can be derived from somatic cells by ectopic expression of different transcription factors, classically Oct4 (also known as Pou5f1), Sox2, Klf4 and Myc (abbreviated as OSKM). This process is accompanied by genome-wide epigenetic changes, but how these...

  • Ä°ndüklenmiÅŸ Pluripotent Kök Hücreler ve Uygulamaları. Sevim, Handan; Gürpinar, Özer Aylin // Marmara Medical Journal;2012, Vol. 25 Issue 1, p5 

    Pluripotency is a property of a cell that allows it to develop as any of the cell types of the body. Embryonic stem cells (ESCs) are unique cells in the organism and they have a pluripotent capacity. Induced pluripotent stem cells (IPSCs) is a term that describes somatic cells having a...

  • The dosage of Patz1 modulates reprogramming process. Hui Ma; Jin Rong Ow; Bobby Cheng Peow Tan; Ziyi Goh; Bo Feng; Yuin Han Loh; Fedele, Monica; Hu Li; Qiang Wu // Scientific Reports;12/19/2014, p1 

    The acquisition of pluripotent cells can be achieved by combined overexpression of transcription factors Oct4, Klf4, Sox2 and c-Myc in somatic cells. This cellular reprogramming process overcomes various barriers to re-activate pluripotency genes and re-acquire the highly dynamic pluripotent...

  • Reprogramming to Pluripotency through a Somatic Stem Cell Intermediate. Marthaler, Adele G.; Tiemann, Ulf; Araúzo-Bravo, Marcos J.; Wu, Guangming; Zaehres, Holm; Hyun, Jung Keun; Han, Dong Wook; Schöler, Hans R.; Tapia, Natalia // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Transcription factor-based reprogramming can lead to the successful switching of cell fates. We have recently reported that mouse embryonic fibroblasts (MEFs) can be directly reprogrammed into induced neural stem cells (iNSCs) after the forced expression of Brn4, Sox2, Klf4, and Myc. Here, we...

  • FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Zhang, Xin; Yalcin, Safak; Lee, Dung-Fang; Yeh, Tsung-Yin J.; Lee, Seung-Min; Su, Jie; Mungamuri, Sathish Kumar; Rimmel�, Pauline; Kennedy, Marion; Sellers, Rani; Landthaler, Markus; Tuschl, Thomas; Chi, Nai-Wen; Lemischka, Ihor; Keller, Gordon; Ghaffari, Saghi // Nature Cell Biology;Sep2011, Vol. 13 Issue 9, p1092 

    Pluripotency of embryonic stem cells (ESCs) is defined by their ability to differentiate into three germ layers and derivative cell types and is established by an interactive network of proteins including OCT4 (also known as POU5F1; ref. ), NANOG (refs , ), SOX2 (ref. ) and their binding...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics